RE: Those lines22 Dec 2021 13:38
Muggins
For debate purposes only, you are correct, with regards the SP performance in 2021. It started at around 33p and will, perhaps, finish around 23p... A swing of 30% is not good (IMHO)
Our interpretations of the reasons for that are different, from your posts, I get that you believe that the BOD's have 'promised' certain things, cruise ship sector involvement as one and the breathalyser as another, DVRG (IYO) have not delivered and therefore the market has reacted negatively.
I, on the other hand believe, the company are in transition ie upgrading technology, developing partnerships, gearing up for mass production and the BOD's have confirmed field trials are ongoing so neither tech or sectors have been shelved, work is on going. Hence SP has suffered due to impatient shareholders, large sellers and a little sentiment manipulation.
There is in fact space for both interpretations as the current SP is just a moment in time. DVRG have targeted April 2022 for Next Gen mass production of MW tech, am not sure which bit of that some folks do not understand, yes there will be STC and other Labskin business to keep shareholders interested, I guess some 2nd gen MWG sales, CR partnership to be announced early Q1 and confirmation of the 2022 revenue etc.
What I, personally, find frustrating is your constant personal attacks on GB. The CEO is an integral part of the business (from what I can tell) but to solely 'blame' (or even praise) him for the overall operations of the company, I find disingenuous (GB's word) to the rest of the staff at DVRG and all the partners/associates who, it seems, have worked incredibly hard in challenging conditions, it also gives one person to much influence.
Open to debate as always
IMHO
ATBM
Sign In
Follow the stocks
